Celularity Inc (CELU)
2.25
-0.01
(-0.44%)
USD |
NASDAQ |
Jan 07, 10:20
Celularity Profit Margin (Quarterly): -173.2% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Dentsply Sirona Inc | -51.95% |
| Ligand Pharmaceuticals Inc | -13.84% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.8% |
| Return on Assets | -24.71% |
| Return on Invested Capital | -50.77% |
| Gross Profit Margin (Quarterly) | 58.23% |
| Operating Margin (Quarterly) | -124.0% |
| Return on Net Operating Assets | -31.53% |